IL13RA2 and glioblastoma: The stronger fluorescent intensity in the Pep-PP@COU-treated C6 cells may be the consequence of the Pep-1-enhanced IL-13Rα2-mediated endocytosis, resulting in the increased uptake of Pep-PP@Res and, consequently, stronger anti-GBM efficacy.